Skip to main content

Animations

MJFF Publications

8701 - 8710 of 8818 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2025
  • 2025
  • 2024
  • 2020
  • 2024
  • 2023
  • 2025
  • 2024
  • Summary Details
    OPEN
    Title: Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28319
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-020-00362-y
    Citation Count: 79
  • Summary Details
    OPEN
    Title: Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/alz.70078
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Using a stable protein scaffold to display peptides that bind to alpha‐synuclein fibrils
    Journal Name: Protein Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/pro.70150
    Citation Count: 0
  • Summary Details
    OPEN
    Title: MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00083-8
    Citation Count: 15
  • Summary Details
    OPEN
    Title: The Human Coronavirus Receptor ANPEP (CD13) Is Overexpressed in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28354
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Dysregulated Wnt and NFAT signaling in a Parkinson’s disease LRRK2 G2019S knock-in model
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-63130-8
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Whole proteome copy number dataset in primary mouse cortical neurons
    Journal Name: Data in Brief
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.dib.2023.109336
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2412029122
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.13859
    Citation Count: 971
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.